aluates Reports

$ 0.0

Automative

Global Preclinical Pharmacology Services Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-26J19480

BUY CHAPTERS

Global Preclinical Pharmacology Services Market Research Report 2025

Code: QYRE-Auto-26J19480

Report

September 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Preclinical Pharmacology Services Market Size

The global market for Preclinical Pharmacology Services was valued at US$ 4622 million in the year 2024 and is projected to reach a revised size of US$ 6862 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Preclinical Pharmacology Services Market

Preclinical pharmacology and efficacy evaluation is a critical bridge between drug discovery and clinical development. Leveraging our specialized rat and mouse models and cell line models, our preclinical pharmacology and efficacy evaluation platform provides pharmaceutical companies and clinical research institutions with efficient drug screening services and precise efficacy assessment support, helping drug candidates overcome R&D bottlenecks and advance efficiently into clinical research.

North American market for Preclinical Pharmacology Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Preclinical Pharmacology Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Preclinical Pharmacology Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Preclinical Pharmacology Services include LabCorp, Charles Rivers, Eurofins Scientific, ICON, WuXi AppTec, Pharmaron, ChemPartner PharmaTech, Joinn Laboratories, Crown Bioscience, PharmaLegacy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Preclinical Pharmacology Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Pharmacology Services.

The Preclinical Pharmacology Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical Pharmacology Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Preclinical Pharmacology Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Preclinical Pharmacology Services Market Report

Report Metric	Details
Report Name	Preclinical Pharmacology Services Market
Accounted market size in year	US$ 4622 million
Forecasted market size in 2031	US$ 6862 million
CAGR	6.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	In-vitro Pharmacology Services In-vivo Pharmacology Services
Segment by Application	Pharmaceutical Companies Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	LabCorp, Charles Rivers, Eurofins Scientific, ICON, WuXi AppTec, Pharmaron, ChemPartner PharmaTech, Joinn Laboratories, Crown Bioscience, PharmaLegacy, GemPharmatech, Shanghai Model Organisms, Biocytogen, PPD, Inc, Inotiv, Shanghai Medicilon, ProBio, Altasciences, Biotrial, Revvity, InnoSer, Cynbiose
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical Pharmacology Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Preclinical Pharmacology Services Market growing?

Ans: The Preclinical Pharmacology Services Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Preclinical Pharmacology Services Market size in 2031?

Ans: The Preclinical Pharmacology Services Market size in 2031 will be US$ 6862 million.

Who are the main players in the Preclinical Pharmacology Services Market report?

Ans: The main players in the Preclinical Pharmacology Services Market are LabCorp, Charles Rivers, Eurofins Scientific, ICON, WuXi AppTec, Pharmaron, ChemPartner PharmaTech, Joinn Laboratories, Crown Bioscience, PharmaLegacy, GemPharmatech, Shanghai Model Organisms, Biocytogen, PPD, Inc, Inotiv, Shanghai Medicilon, ProBio, Altasciences, Biotrial, Revvity, InnoSer, Cynbiose

What are the Application segmentation covered in the Preclinical Pharmacology Services Market report?

Ans: The Applications covered in the Preclinical Pharmacology Services Market report are Pharmaceutical Companies, Clinical Research

What are the Type segmentation covered in the Preclinical Pharmacology Services Market report?

Ans: The Types covered in the Preclinical Pharmacology Services Market report are In-vitro Pharmacology Services, In-vivo Pharmacology Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Preclinical Pharmacology Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 In-vitro Pharmacology Services

1.2.3 In-vivo Pharmacology Services

1.3 Market by Application

1.3.1 Global Preclinical Pharmacology Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Clinical Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Preclinical Pharmacology Services Market Perspective (2020-2031)

2.2 Global Preclinical Pharmacology Services Growth Trends by Region

2.2.1 Global Preclinical Pharmacology Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Preclinical Pharmacology Services Historic Market Size by Region (2020-2025)

2.2.3 Preclinical Pharmacology Services Forecasted Market Size by Region (2026-2031)

2.3 Preclinical Pharmacology Services Market Dynamics

2.3.1 Preclinical Pharmacology Services Industry Trends

2.3.2 Preclinical Pharmacology Services Market Drivers

2.3.3 Preclinical Pharmacology Services Market Challenges

2.3.4 Preclinical Pharmacology Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Preclinical Pharmacology Services Players by Revenue

3.1.1 Global Top Preclinical Pharmacology Services Players by Revenue (2020-2025)

3.1.2 Global Preclinical Pharmacology Services Revenue Market Share by Players (2020-2025)

3.2 Global Top Preclinical Pharmacology Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Preclinical Pharmacology Services Revenue

3.4 Global Preclinical Pharmacology Services Market Concentration Ratio

3.4.1 Global Preclinical Pharmacology Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Preclinical Pharmacology Services Revenue in 2024

3.5 Global Key Players of Preclinical Pharmacology Services Head office and Area Served

3.6 Global Key Players of Preclinical Pharmacology Services, Product and Application

3.7 Global Key Players of Preclinical Pharmacology Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical Pharmacology Services Breakdown Data by Type

4.1 Global Preclinical Pharmacology Services Historic Market Size by Type (2020-2025)

4.2 Global Preclinical Pharmacology Services Forecasted Market Size by Type (2026-2031)

5 Preclinical Pharmacology Services Breakdown Data by Application

5.1 Global Preclinical Pharmacology Services Historic Market Size by Application (2020-2025)

5.2 Global Preclinical Pharmacology Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Preclinical Pharmacology Services Market Size (2020-2031)

6.2 North America Preclinical Pharmacology Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Preclinical Pharmacology Services Market Size by Country (2020-2025)

6.4 North America Preclinical Pharmacology Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Preclinical Pharmacology Services Market Size (2020-2031)

7.2 Europe Preclinical Pharmacology Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Preclinical Pharmacology Services Market Size by Country (2020-2025)

7.4 Europe Preclinical Pharmacology Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Preclinical Pharmacology Services Market Size (2020-2031)

8.2 Asia-Pacific Preclinical Pharmacology Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Preclinical Pharmacology Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Preclinical Pharmacology Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Preclinical Pharmacology Services Market Size (2020-2031)

9.2 Latin America Preclinical Pharmacology Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Preclinical Pharmacology Services Market Size by Country (2020-2025)

9.4 Latin America Preclinical Pharmacology Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preclinical Pharmacology Services Market Size (2020-2031)

10.2 Middle East & Africa Preclinical Pharmacology Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Preclinical Pharmacology Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Preclinical Pharmacology Services Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 LabCorp

11.1.1 LabCorp Company Details

11.1.2 LabCorp Business Overview

11.1.3 LabCorp Preclinical Pharmacology Services Introduction

11.1.4 LabCorp Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.1.5 LabCorp Recent Development

11.2 Charles Rivers

11.2.1 Charles Rivers Company Details

11.2.2 Charles Rivers Business Overview

11.2.3 Charles Rivers Preclinical Pharmacology Services Introduction

11.2.4 Charles Rivers Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.2.5 Charles Rivers Recent Development

11.3 Eurofins Scientific

11.3.1 Eurofins Scientific Company Details

11.3.2 Eurofins Scientific Business Overview

11.3.3 Eurofins Scientific Preclinical Pharmacology Services Introduction

11.3.4 Eurofins Scientific Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.3.5 Eurofins Scientific Recent Development

11.4 ICON

11.4.1 ICON Company Details

11.4.2 ICON Business Overview

11.4.3 ICON Preclinical Pharmacology Services Introduction

11.4.4 ICON Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.4.5 ICON Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec Preclinical Pharmacology Services Introduction

11.5.4 WuXi AppTec Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.5.5 WuXi AppTec Recent Development

11.6 Pharmaron

11.6.1 Pharmaron Company Details

11.6.2 Pharmaron Business Overview

11.6.3 Pharmaron Preclinical Pharmacology Services Introduction

11.6.4 Pharmaron Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.6.5 Pharmaron Recent Development

11.7 ChemPartner PharmaTech

11.7.1 ChemPartner PharmaTech Company Details

11.7.2 ChemPartner PharmaTech Business Overview

11.7.3 ChemPartner PharmaTech Preclinical Pharmacology Services Introduction

11.7.4 ChemPartner PharmaTech Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.7.5 ChemPartner PharmaTech Recent Development

11.8 Joinn Laboratories

11.8.1 Joinn Laboratories Company Details

11.8.2 Joinn Laboratories Business Overview

11.8.3 Joinn Laboratories Preclinical Pharmacology Services Introduction

11.8.4 Joinn Laboratories Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.8.5 Joinn Laboratories Recent Development

11.9 Crown Bioscience

11.9.1 Crown Bioscience Company Details

11.9.2 Crown Bioscience Business Overview

11.9.3 Crown Bioscience Preclinical Pharmacology Services Introduction

11.9.4 Crown Bioscience Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.9.5 Crown Bioscience Recent Development

11.10 PharmaLegacy

11.10.1 PharmaLegacy Company Details

11.10.2 PharmaLegacy Business Overview

11.10.3 PharmaLegacy Preclinical Pharmacology Services Introduction

11.10.4 PharmaLegacy Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.10.5 PharmaLegacy Recent Development

11.11 GemPharmatech

11.11.1 GemPharmatech Company Details

11.11.2 GemPharmatech Business Overview

11.11.3 GemPharmatech Preclinical Pharmacology Services Introduction

11.11.4 GemPharmatech Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.11.5 GemPharmatech Recent Development

11.12 Shanghai Model Organisms

11.12.1 Shanghai Model Organisms Company Details

11.12.2 Shanghai Model Organisms Business Overview

11.12.3 Shanghai Model Organisms Preclinical Pharmacology Services Introduction

11.12.4 Shanghai Model Organisms Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.12.5 Shanghai Model Organisms Recent Development

11.13 Biocytogen

11.13.1 Biocytogen Company Details

11.13.2 Biocytogen Business Overview

11.13.3 Biocytogen Preclinical Pharmacology Services Introduction

11.13.4 Biocytogen Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.13.5 Biocytogen Recent Development

11.14 PPD, Inc

11.14.1 PPD, Inc Company Details

11.14.2 PPD, Inc Business Overview

11.14.3 PPD, Inc Preclinical Pharmacology Services Introduction

11.14.4 PPD, Inc Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.14.5 PPD, Inc Recent Development

11.15 Inotiv

11.15.1 Inotiv Company Details

11.15.2 Inotiv Business Overview

11.15.3 Inotiv Preclinical Pharmacology Services Introduction

11.15.4 Inotiv Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.15.5 Inotiv Recent Development

11.16 Shanghai Medicilon

11.16.1 Shanghai Medicilon Company Details

11.16.2 Shanghai Medicilon Business Overview

11.16.3 Shanghai Medicilon Preclinical Pharmacology Services Introduction

11.16.4 Shanghai Medicilon Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.16.5 Shanghai Medicilon Recent Development

11.17 ProBio

11.17.1 ProBio Company Details

11.17.2 ProBio Business Overview

11.17.3 ProBio Preclinical Pharmacology Services Introduction

11.17.4 ProBio Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.17.5 ProBio Recent Development

11.18 Altasciences

11.18.1 Altasciences Company Details

11.18.2 Altasciences Business Overview

11.18.3 Altasciences Preclinical Pharmacology Services Introduction

11.18.4 Altasciences Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.18.5 Altasciences Recent Development

11.19 Biotrial

11.19.1 Biotrial Company Details

11.19.2 Biotrial Business Overview

11.19.3 Biotrial Preclinical Pharmacology Services Introduction

11.19.4 Biotrial Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.19.5 Biotrial Recent Development

11.20 Revvity

11.20.1 Revvity Company Details

11.20.2 Revvity Business Overview

11.20.3 Revvity Preclinical Pharmacology Services Introduction

11.20.4 Revvity Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.20.5 Revvity Recent Development

11.21 InnoSer

11.21.1 InnoSer Company Details

11.21.2 InnoSer Business Overview

11.21.3 InnoSer Preclinical Pharmacology Services Introduction

11.21.4 InnoSer Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.21.5 InnoSer Recent Development

11.22 Cynbiose

11.22.1 Cynbiose Company Details

11.22.2 Cynbiose Business Overview

11.22.3 Cynbiose Preclinical Pharmacology Services Introduction

11.22.4 Cynbiose Revenue in Preclinical Pharmacology Services Business (2020-2025)

11.22.5 Cynbiose Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Preclinical Pharmacology Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of In-vitro Pharmacology Services

Table 3. Key Players of In-vivo Pharmacology Services

Table 4. Global Preclinical Pharmacology Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Preclinical Pharmacology Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Preclinical Pharmacology Services Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Preclinical Pharmacology Services Market Share by Region (2020-2025)

Table 8. Global Preclinical Pharmacology Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Preclinical Pharmacology Services Market Share by Region (2026-2031)

Table 10. Preclinical Pharmacology Services Market Trends

Table 11. Preclinical Pharmacology Services Market Drivers

Table 12. Preclinical Pharmacology Services Market Challenges

Table 13. Preclinical Pharmacology Services Market Restraints

Table 14. Global Preclinical Pharmacology Services Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Preclinical Pharmacology Services Market Share by Players (2020-2025)

Table 16. Global Top Preclinical Pharmacology Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Pharmacology Services as of 2024)

Table 17. Ranking of Global Top Preclinical Pharmacology Services Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Preclinical Pharmacology Services Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Preclinical Pharmacology Services, Headquarters and Area Served

Table 20. Global Key Players of Preclinical Pharmacology Services, Product and Application

Table 21. Global Key Players of Preclinical Pharmacology Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Preclinical Pharmacology Services Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Preclinical Pharmacology Services Revenue Market Share by Type (2020-2025)

Table 25. Global Preclinical Pharmacology Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Preclinical Pharmacology Services Revenue Market Share by Type (2026-2031)

Table 27. Global Preclinical Pharmacology Services Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Preclinical Pharmacology Services Revenue Market Share by Application (2020-2025)

Table 29. Global Preclinical Pharmacology Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Preclinical Pharmacology Services Revenue Market Share by Application (2026-2031)

Table 31. North America Preclinical Pharmacology Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Preclinical Pharmacology Services Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Preclinical Pharmacology Services Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Preclinical Pharmacology Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Preclinical Pharmacology Services Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Preclinical Pharmacology Services Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Preclinical Pharmacology Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Preclinical Pharmacology Services Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Preclinical Pharmacology Services Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Preclinical Pharmacology Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Preclinical Pharmacology Services Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Preclinical Pharmacology Services Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Preclinical Pharmacology Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Preclinical Pharmacology Services Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Preclinical Pharmacology Services Market Size by Country (2026-2031) & (US$ Million)

Table 46. LabCorp Company Details

Table 47. LabCorp Business Overview

Table 48. LabCorp Preclinical Pharmacology Services Product

Table 49. LabCorp Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 50. LabCorp Recent Development

Table 51. Charles Rivers Company Details

Table 52. Charles Rivers Business Overview

Table 53. Charles Rivers Preclinical Pharmacology Services Product

Table 54. Charles Rivers Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 55. Charles Rivers Recent Development

Table 56. Eurofins Scientific Company Details

Table 57. Eurofins Scientific Business Overview

Table 58. Eurofins Scientific Preclinical Pharmacology Services Product

Table 59. Eurofins Scientific Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 60. Eurofins Scientific Recent Development

Table 61. ICON Company Details

Table 62. ICON Business Overview

Table 63. ICON Preclinical Pharmacology Services Product

Table 64. ICON Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 65. ICON Recent Development

Table 66. WuXi AppTec Company Details

Table 67. WuXi AppTec Business Overview

Table 68. WuXi AppTec Preclinical Pharmacology Services Product

Table 69. WuXi AppTec Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 70. WuXi AppTec Recent Development

Table 71. Pharmaron Company Details

Table 72. Pharmaron Business Overview

Table 73. Pharmaron Preclinical Pharmacology Services Product

Table 74. Pharmaron Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 75. Pharmaron Recent Development

Table 76. ChemPartner PharmaTech Company Details

Table 77. ChemPartner PharmaTech Business Overview

Table 78. ChemPartner PharmaTech Preclinical Pharmacology Services Product

Table 79. ChemPartner PharmaTech Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 80. ChemPartner PharmaTech Recent Development

Table 81. Joinn Laboratories Company Details

Table 82. Joinn Laboratories Business Overview

Table 83. Joinn Laboratories Preclinical Pharmacology Services Product

Table 84. Joinn Laboratories Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 85. Joinn Laboratories Recent Development

Table 86. Crown Bioscience Company Details

Table 87. Crown Bioscience Business Overview

Table 88. Crown Bioscience Preclinical Pharmacology Services Product

Table 89. Crown Bioscience Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 90. Crown Bioscience Recent Development

Table 91. PharmaLegacy Company Details

Table 92. PharmaLegacy Business Overview

Table 93. PharmaLegacy Preclinical Pharmacology Services Product

Table 94. PharmaLegacy Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 95. PharmaLegacy Recent Development

Table 96. GemPharmatech Company Details

Table 97. GemPharmatech Business Overview

Table 98. GemPharmatech Preclinical Pharmacology Services Product

Table 99. GemPharmatech Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 100. GemPharmatech Recent Development

Table 101. Shanghai Model Organisms Company Details

Table 102. Shanghai Model Organisms Business Overview

Table 103. Shanghai Model Organisms Preclinical Pharmacology Services Product

Table 104. Shanghai Model Organisms Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 105. Shanghai Model Organisms Recent Development

Table 106. Biocytogen Company Details

Table 107. Biocytogen Business Overview

Table 108. Biocytogen Preclinical Pharmacology Services Product

Table 109. Biocytogen Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 110. Biocytogen Recent Development

Table 111. PPD, Inc Company Details

Table 112. PPD, Inc Business Overview

Table 113. PPD, Inc Preclinical Pharmacology Services Product

Table 114. PPD, Inc Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 115. PPD, Inc Recent Development

Table 116. Inotiv Company Details

Table 117. Inotiv Business Overview

Table 118. Inotiv Preclinical Pharmacology Services Product

Table 119. Inotiv Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 120. Inotiv Recent Development

Table 121. Shanghai Medicilon Company Details

Table 122. Shanghai Medicilon Business Overview

Table 123. Shanghai Medicilon Preclinical Pharmacology Services Product

Table 124. Shanghai Medicilon Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 125. Shanghai Medicilon Recent Development

Table 126. ProBio Company Details

Table 127. ProBio Business Overview

Table 128. ProBio Preclinical Pharmacology Services Product

Table 129. ProBio Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 130. ProBio Recent Development

Table 131. Altasciences Company Details

Table 132. Altasciences Business Overview

Table 133. Altasciences Preclinical Pharmacology Services Product

Table 134. Altasciences Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 135. Altasciences Recent Development

Table 136. Biotrial Company Details

Table 137. Biotrial Business Overview

Table 138. Biotrial Preclinical Pharmacology Services Product

Table 139. Biotrial Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 140. Biotrial Recent Development

Table 141. Revvity Company Details

Table 142. Revvity Business Overview

Table 143. Revvity Preclinical Pharmacology Services Product

Table 144. Revvity Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 145. Revvity Recent Development

Table 146. InnoSer Company Details

Table 147. InnoSer Business Overview

Table 148. InnoSer Preclinical Pharmacology Services Product

Table 149. InnoSer Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 150. InnoSer Recent Development

Table 151. Cynbiose Company Details

Table 152. Cynbiose Business Overview

Table 153. Cynbiose Preclinical Pharmacology Services Product

Table 154. Cynbiose Revenue in Preclinical Pharmacology Services Business (2020-2025) & (US$ Million)

Table 155. Cynbiose Recent Development

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

Table 159. Authors List of This Report

List of Figures

Figure 1. Preclinical Pharmacology Services Picture

Figure 2. Global Preclinical Pharmacology Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Preclinical Pharmacology Services Market Share by Type: 2024 VS 2031

Figure 4. In-vitro Pharmacology Services Features

Figure 5. In-vivo Pharmacology Services Features

Figure 6. Global Preclinical Pharmacology Services Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Preclinical Pharmacology Services Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Clinical Research Case Studies

Figure 10. Preclinical Pharmacology Services Report Years Considered

Figure 11. Global Preclinical Pharmacology Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Preclinical Pharmacology Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Preclinical Pharmacology Services Market Share by Region: 2024 VS 2031

Figure 14. Global Preclinical Pharmacology Services Market Share by Players in 2024

Figure 15. Global Preclinical Pharmacology Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Preclinical Pharmacology Services Revenue in 2024

Figure 17. North America Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Preclinical Pharmacology Services Market Share by Country (2020-2031)

Figure 19. United States Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Preclinical Pharmacology Services Market Share by Country (2020-2031)

Figure 23. Germany Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Ireland Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Preclinical Pharmacology Services Market Share by Region (2020-2031)

Figure 31. China Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia & New Zealand Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Preclinical Pharmacology Services Market Share by Country (2020-2031)

Figure 39. Mexico Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Preclinical Pharmacology Services Market Share by Country (2020-2031)

Figure 43. Israel Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Preclinical Pharmacology Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. LabCorp Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 47. Charles Rivers Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 48. Eurofins Scientific Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 49. ICON Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 50. WuXi AppTec Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 51. Pharmaron Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 52. ChemPartner PharmaTech Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 53. Joinn Laboratories Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 54. Crown Bioscience Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 55. PharmaLegacy Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 56. GemPharmatech Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 57. Shanghai Model Organisms Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 58. Biocytogen Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 59. PPD, Inc Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 60. Inotiv Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 61. Shanghai Medicilon Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 62. ProBio Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 63. Altasciences Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 64. Biotrial Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 65. Revvity Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 66. InnoSer Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 67. Cynbiose Revenue Growth Rate in Preclinical Pharmacology Services Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Preclinical Pharmacology Services Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-26J19480

Global Preclinical Pharmacology Services Market Research Report 2025

FEATURED COMPANIES

Preclinical Pharmacology Services Market Size

Preclinical Pharmacology Services Market

Scope of Preclinical Pharmacology Services Market Report

Chapter Outline

FAQ for this report

How fast is Preclinical Pharmacology Services Market growing?

What is the Preclinical Pharmacology Services Market size in 2031?

Who are the main players in the Preclinical Pharmacology Services Market report?

What are the Application segmentation covered in the Preclinical Pharmacology Services Market report?

What are the Type segmentation covered in the Preclinical Pharmacology Services Market report?

FEATURED COMPANIES